According to an analysis conducted by healthcare data company Truveris earlier this year, prescription drug inflation topped 10% in 2015, spearheaded by an average price increase in branded pharmaceuticals of 14.77%. In September, the "Bad Boy of Pharma," Martin Shkreli, drew unwanted attention after his company, Turing Pharmaceuticals, acquired a rare disease drug known as Daraprim and promptly raised its price by roughly 5,500%. Democratic presidential nominee Hillary Clinton earlier this month offered up the idea of creating a federal task force whose job would be to act as a watchdog for excessive drug price hikes.